MediXall Group, Inc. (MDXL)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.56 Million | -4.68 Million | -3.5 Million | -2.34 Million | -2.22 Million | -2.06 Million |
| Net Income | -6.83 Million | -6.2 Million | -5.93 Million | -3.42 Million | -2.98 Million | -1.64 Million |
| Depreciation & Amortization | 35.71 Thousand | 4000.00 | 4000.00 | 69.94 Thousand | 3145.00 | 3000.00 |
| Deferred income taxes | -1.68 Million | -1.36 Million | - | -643.25 Thousand | - | - |
| Stock-based compensation | 1.96 Million | 1.36 Million | 1.66 Million | 643.25 Thousand | 997.76 Thousand | - |
| Change in working capital | 876.97 Thousand | 330.74 Thousand | 137.25 Thousand | 365.71 Thousand | -335.39 Thousand | -428.22 Thousand |
| Other non-cash items | 2.07 Million | 1.18 Million | 623.58 Thousand | 643.25 Thousand | 1 Million | -641.17 |
| Investing Cash Flow | -1379.00 | -12.84 Thousand | -715.15 Thousand | -15.74 Thousand | -281.54 Thousand | -179.3 Thousand |
| Investments in PPE | -1379.00 | -12.84 Thousand | -91.57 Thousand | -15.74 Thousand | -281.54 Thousand | -179.3 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1379.00 | -12.00 | -623.58 Thousand | -5.25 | -274.25 | -163.87 |
| Financing Cash Flow | 3.5 Million | 4.11 Million | 4.41 Million | 2602.50 | 2.51 Million | 2.32 Million |
| Debt repayment | -2.72 Million | - | -165.71 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 780.5 Thousand | 1.84 Million | 2.61 Million | 2.6 Million | 2.51 Million | 2.32 Million |
| Other Financing Activities | 2.72 Million | 2.26 Million | 1.8 Million | 2602.50 | 2516.86 | 2461.73 |
| Accounts receivables | - | - | 623.58 Thousand | 160.59 Thousand | -138.79 Thousand | -21.79 |
| Accounts payables | 552.07 Thousand | 17.46 Thousand | 410.62 Thousand | 26.95 Thousand | -196.59 Thousand | -428.22 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 324.89 Thousand | 313.27 Thousand | -896.95 Thousand | 178.16 Thousand | - | - |
| Cash at beginning of period | 63.41 Thousand | 645.76 Thousand | 446.21 Thousand | 201.5 Thousand | 191.44 Thousand | 114.97 Thousand |
| Cash at end of period | 3416.00 | 63.41 Thousand | 645.76 Thousand | 446.21 Thousand | 201.5 Thousand | 191.44 Thousand |
| Capital Expenditure | -1379.00 | -12.84 Thousand | -91.57 Thousand | -15.74 Thousand | -281.54 Thousand | -179.3 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -60 Thousand | -582.34 Thousand | 199.54 Thousand | 244.71 Thousand | 10.06 Thousand | 76.46 Thousand |
| Free Cash Flow | -3.56 Million | -4.69 Million | -3.59 Million | -2.35 Million | -2.5 Million | -2.24 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -908.06 Thousand | -979.37 Thousand | -1.22 Million | -1.78 Million | -6.83 Million | -1.08 Million |
| Depreciation & Amortization | 129.21 Thousand | 14.31 Thousand | 4460.00 | 34.09 Thousand | 35.71 Thousand | -2059.00 |
| Deferred income taxes | - | - | - | -747.23 Thousand | -1.68 Million | 242.7 Thousand |
| Stock-based compensation | 467.98 Thousand | 467.98 Thousand | 467.98 Thousand | 747.23 Thousand | 1.96 Million | -242.7 Thousand |
| Change in working capital | -17.2 Thousand | -89.13 Thousand | 451.87 Thousand | 70.82 Thousand | 876.97 Thousand | 376.86 Thousand |
| Other non-cash items | 64.15 Thousand | 673.82 Thousand | 381.35 Thousand | 1.07 Million | 2.07 Million | -188.84 Thousand |
| Investing Cash Flow | - | - | - | -1379.00 | -1379.00 | 1680.00 |
| Investments in PPE | -2.00 | - | - | -1379.00 | -1379.00 | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -3059.00 | -1379.00 | 1680.00 |
| Financing Cash Flow | 255.01 Thousand | 396.66 Thousand | 382.67 Thousand | 527.49 Thousand | 3.5 Million | 797.97 Thousand |
| Debt repayment | -255.01 Thousand | -396.66 Thousand | -380.82 Thousand | -507.49 Thousand | -2.72 Million | -797.97 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 1853.00 | 20 Thousand | 780.5 Thousand | - |
| Other Financing Activities | 255.01 Thousand | 396.66 Thousand | 1.85 | 507.49 Thousand | 2.72 Million | 797.97 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 84.8 Thousand | - | - | 52.83 Thousand | 552.07 Thousand | 351.39 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -102 Thousand | -136.61 Thousand | 233.64 Thousand | 70.82 Thousand | 324.89 Thousand | 25.46 Thousand |
| Cash at beginning of period | 18.57 Thousand | 2289.00 | 3416.00 | 75.57 Thousand | 63.41 Thousand | 173.84 Thousand |
| Cash at end of period | 9667.00 | 18.57 Thousand | 2289.00 | 3416.00 | 3416.00 | 75.57 Thousand |
| Capital Expenditure | -2.00 | - | - | -1379.00 | -1379.00 | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -8906.00 | 16.28 Thousand | -1127.00 | -72.16 Thousand | -60 Thousand | -98.26 Thousand |
| Free Cash Flow | -263.92 Thousand | -380.38 Thousand | -383.8 Thousand | -599.66 Thousand | -3.56 Million | -897.91 Thousand |
SBGOF
LICN
KARO
PBEE
OABIW
0L6Z